Kayode Ogungbenro

Lecturer

The University of Manchester

United Kingdom

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacology

90%

Pharmacotherapy

50%

Pharmacokinetic

60%

Pharmacometrics

50%

Cancer Biology

30%

Ex Vivo Studies

20%

Drug Transport

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles14

Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid Arthritis

Article Link

Year:

2024

Hierarchical cluster analysis and nonlinear mixed-effects modelling for candidate biomarker detection in preclinical models of cancer.

Article Link

Year:

2024

Mixed effects modeling of radiotherapy in combination with immune checkpoint blockade or inhibitors of the DNA damage response pathway

Article Link

Year:

2023

Estimation of FMO3 Ontogeny by Mechanistic Population Pharmacokinetic Modelling of Risdiplam and Its Impact on Drug–Drug Interactions in Children

Article Link

Year:

2023

A “middle‐out approach” for the prediction of human drug disposition from preclinical data using simplified physiologically based pharmacokinetic (PBPK) models

Article Link

Year:

2023

Use of In Vivo Imaging and Physiologically-Based Kinetic Modelling to Predict Hepatic Transporter Mediated Drug–Drug Interactions in Rats

Article Link

Year:

2023

Covariates in population pharmacokinetic studies of critically ill adults receiving β-lactam antimicrobials: a systematic review and narrative synthesis

Article Link

Year:

2023

Exploring the boundaries for in vitro-in vivo extrapolation

Article Link

Year:

2023

Radiation in Combination with Immune Checkpoint Blockade and DNA Damage Response Inhibitors in Mice

Article Link

Year:

2023

Development of a sensitive biochemical assay for the detection of tofacitinib adherence

Article Link

Year:

2023

In Vitro to In Vivo Extrapolation Linked to Physiologically Based Pharmacokinetic Models for Assessing the Brain Drug Disposition

Article Link

Year:

2022

Coproporphyrin I as an endogenous biomarker to detect reduced OATP1B activity and shift in elimination route in chronic kidney disease

Article Link

Year:

2022

Evaluation of area under the concentration curve adjusted by the terminal‐phase as a metric to reduce the impact of variability in bioequivalence testing

Article Link

Year:

2022

Dose individualisation in oncology using chemotherapy‐induced neutropenia: Example of docetaxel in non‐small cell lung cancer patients

Article Link

Year:

2021

Collaborators8

Alexander G Mathioudakis

The University of Manchester

UNITED KINGDOM

Hitesh Mistry

The University of Manchester

UNITED KINGDOM

John C. Waterton

The University of Manchester

UNITED KINGDOM

Sian Bladon

The University of Manchester

UNITED KINGDOM

James Bluett

Manchester University NHS Foundation Trust

UNITED KINGDOM

Zubida M. Al-Majdoub

The University of Manchester

UNITED KINGDOM

Daniel Scotcher

The University of Manchester

UNITED KINGDOM

Steven P. Sourbron

UNITED KINGDOM

How do I reach out?

Meet Kite AI